T409-0477 Screening compound: 2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

T409-0477 Screening compound: 2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide
T409-0477 Screening compound: 2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T409-0477
2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T409-0477

Molecular Formula

C22H28N4O3S (C22 H28 N4 O3 S)

Compound Name

2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

IUPAC name

2-(4-cyclobutanecarbonylpiperazin-1-yl)-N-[(furan-2-yl)methyl]-4567-tetrahydro-13-benzothiazole-6-carboxamide

SMILES

O=C(C1CCC1)N(CC1)CCN1c1nc(CCC(C2)C(NCc3ccco3)=O)c2s1

InChI

InChI=1S/C22H28N4O3S/c27-20(23-14-17-5-2-12-29-17)16-6-7-18-19(13-16)30-22(24-18)26-10-8-25(9-11-26)21(28)15-3-1-4-15/h2,5,12,15-16H,1,3-4,6-11,13-14H2,(H,23,27)/t16-/m1/s1

InChI Key

DCVYHJWLDQNHGB-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD29023830

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.764

Distribution Coefficient, logD

2.658

Water Solubility, LogSw

-3.12

Polar Surface Area

64.074

Acid Dissociation Constant (pKa)

11.77

Base Dissociation Constant (pKb)

6.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

59.10

T409-0477 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T409-0477 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T409-0477?
Check Price and Availability of T409-0477, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T409-0477 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T409-0477
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T409-0477
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T409-0477 available by request